Skip to main content
. 2010 Aug 19;12(10):1037–1040. doi: 10.1093/ntr/ntq134

Table 1.

Baseline characteristics (N = 20)a of smokeless tobacco (ST) users enrolled in a pilot study of varenicline for ST reduction

Characteristic
Age, years 42.8 ± 11.7
    Range 24–65
Male, n (%) 20 (100)
Caucasian, n (%) 17 (85)
Marital status, n (%)
    Married/living as married 17 (85)
    Never married 1 (5)
    Separated/divorced 2 (10)
Highest level of education, n (%)
    <High school graduate 1 (5)
    High school graduate 3 (15)
    Some college 5 (25)
    College graduate 11 (55)
Current type of smokeless tobacco used, n (%)
    Snuff 18 (90)
    Chewing tobacco 1 (5)
    Gutkha 1 (5)
Average age started using smokeless tobacco, years 23.0 ± 11.6
    Range 6–56
Smokeless tobacco used per week, cans/pouchesb 3.9 ± 1.7
    Range 2–7
Years of regular smokeless tobacco use, years 18.6 ± 8.6
    Range 6–40
Current use of other tobacco productsc, n (%) 1 (5)
Other users of tobacco in household, n (%) 4 (20)
Number of closest friends who use ST
    None 8 (40)
    1 5 (25)
    2 6 (30)
    3 1 (5)
Number of serious stop attempts (≥24 hr), n (%)
    0 4 (20)
    1–2 3 (15)
    3–4 7 (35)
    5+ 6 (30)
Longest time off tobacco, n (%)
    <24 hr 3 (16)
    1–7 days 3 (16)
    2–8 weeks 7 (37)
    9 weeks to 6 months 1 (5)
    >6 months 5 (26)
Fagerström Test for Nicotine Dependence–Smokeless Tobacco 5.9 ± 1.7
    Range 2–8
Confidence in being tobacco free in 1 year
    Not at all confident 0 (0)
    Not very confident 0 (0)
    Somewhat confident 11 (55)
    Very confident 6 (30)
    Completely confident 3 (15)

Note. aData are presented as mean ± SD, range, or n (%) as indicated.

b

Summary excludes one subject who used gutkha.

c

In addition to smokeless tobacco, one subject reported smoking cigarettes (2 cigarettes/day).